Key result
ApoE deficiency in mice prevents obesity and improves glucose tolerance but worsens NLRP3-driven adipose inflammation.
Why the study?
The mechanisms governing how the organism maintains equilibrium between chronic inflammation and metabolism remain poorly understood.
ApoE deficiency protects against diet-induced obesity and insulin resistance but exacerbates adipose tissue inflammation via the NLRP3 inflammasome, highlighting a dual role in immunometabolism.
Hypothesis-generating for ATM equilibrium in obesity inflammation; leaves open therapeutic targeting pending validation.
Obesity is a metabolic disorder characterized by the hypertrophy expansion of adipose tissue, resulting in dysregulated energy metabolism, and accompanied by chronic low-grade inflammation. Adipose tissue macrophages (ATMs), a principal component of inflammation, respond to microenvironment signals and modulate adipose tissue remodeling and metabolic processes situation-specific. However, the mechanisms governing how the organism maintains equilibrium between its chronic inflammation and metabolism still need to be understood. Here, we describe a novel role of apolipoprotein E (ApoE), which associated with lipid particles, in maintaining fat deposition and system metabolic inflammation. Using human samples and mouse models, we show that ApoE is robustly downregulated in obese individuals, db/db mice, and mice of high-fat diet (HFD) feeding and increased in obese subjects with diabetes. Furthermore, we found that ApoE deficiency mice globally prevented obesity by restraining adipose tissue expansion and improved systemic glucose tolerance and insulin sensitivity. However, macrophage contributed to metabolic inflammation due to increased IL-1β production in adipose tissue from ApoE -/- mice induced by HFD. Our results suggest that the role of ApoE in regulating obesity and obesity-associated glucose dysregulation is inconsistent. Mechanistically, ApoE modulates of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome priming and activation step. Thus, our studies might provide new sights into ApoE, which is required for obesity-induced hyperglycemia, hyperinsulinism, and adaptive inflammation responses but diminishes the tolerance towards a subsequent metabolic inflammatory challenge. Our study shed new light on the integral role of apolipoprotein APOE in immunometabolism and adipose tissue homeostasis.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) studied Obesity and metabolic inflammation (n=47). ApoE deficiency vs. Wild-type (WT) mice and lean human subjects was evaluated on Adipose tissue inflammation, body weight, and glucose tolerance. ApoE deficiency in mice prevented high-fat diet-induced obesity and improved systemic glucose tolerance, but exacerbated adipose tissue inflammation via the NLRP3 inflammasome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: